Alexander B. Olawaiye
Dr. Alexander B. Olawaiye is the director of gynecological cancer research at Magee-Women’s Hospital at the University of Pittsburgh. He is a principal investigator in the ROSELLA trial, which explores the efficacy of the new drug Relacorilant in treating treatment-resistant ovarian cancer, showing promising results in improving overall survival rates.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United States | 1 | 8.00 | 0.03% | +0% | 331,002,651 | 99,341 | $21,000,000 | 6,303$ |
| Totals | 1 | 331,002,651 | 99,341 | $21,000,000 | 6,303$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
Alexander B. Olawaiye, MD, director of gynecological cancer research at Magee-Women’s Hospital at the University of Pittsburgh and principal investigator in the ROSELLA trial, discussed the results with Fox News Digital.
8